Human CNTF Recombinant Protein, PeproTech and 1 more item

Life Technologies Corporation was awarded contract A207_PO-0444476-V3 by the University of Virginia on July 11, 2026, with a cumulative contract value of $1,088.96. This procurement is classified under Virginia state contracting and involves the supply of specialized recombinant proteins for delivery to the University of Virginia as the buyer. The contract encompasses two distinct line items: Human Ciliary Neurotrophic Factor (CNTF) Recombinant Protein sourced from PeproTech, and Human Leukemia Inhibitory Factor (LIF) Recombinant Protein, also from PeproTech.

Under the terms of this award, Life Technologies Corporation is obligated to deliver 562 units of Human CNTF Recombinant Protein and 526 units of Human LIF Recombinant Protein, with each unit priced at $1.00. These biological reagents are commonly utilized in research and developmental applications within academic and institutional laboratory settings. The relatively modest contract value and unit-based pricing structure suggest this procurement represents a consumable supply agreement supporting the University of Virginia's research operations, though the specific performance period is not detailed in the available contract documentation.